We are live on
!
Find out more
NC
Naman Capital Portfolio holdings
AUM
$323M
1-Year Est. Return
37.1%
This Fund
S&P 500
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+37.1%
3 Year Est. Return
+89.87%
5 Year Est. Return
+144.41%
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$21.2M
(+27%)
Cap. Flow
-$39.2M
Cap. Flow
% of AUM
-38.99%
Top 10 Holdings %
Top 10 Hldgs %
88.53%
Holding
18
New
1
Increased
7
Reduced
6
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$9.32M |
| 2 |
Merck
MRK
|
+$9.05M |
| 3 |
ProShares Short S&P500
SH
|
+$6.81M |
| 4 |
Oracle
ORCL
|
+$6.49M |
| 5 |
Gilead Sciences
GILD
|
+$3.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Kraft Heinz Company
KHC
|
+$34.7M |
| 2 |
PepsiCo
PEP
|
+$8.45M |
| 3 |
Qualcomm
QCOM
|
+$7.98M |
| 4 |
Walt Disney
DIS
|
+$7.96M |
| 5 |
Restaurant Brands International
QSR
|
+$4.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.78% |
| 2 | Technology | 18.45% |
| 3 | Miscellaneous | 14.55% |
| 4 | Consumer Staples | 12.92% |
| 5 | Communication Services | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ProShares Short S&P500
SH
$914M
| $14.6M | 14.55% |
137,500
+62,500
| +83% | +$6.81M |
|
|
2
Gilead Sciences
GILD
$187B
| $11.5M | 11.42% |
170,000
+57,479
| +51% | +$3.78M |
|
3
Pfizer
PFE
$158B
| $10.4M | 10.34% |
252,960
-105,400
| -29% | -$4.19M |
|
|
4
Merck
MRK
$363B
| $10.1M | 10.01% |
125,760
+118,250
| +1,575% | +$9.05M |
|
|
ATVI
5
DELISTED
Activision Blizzard
ATVI
| $9.44M | 9.39% |
200,000
+50,000
| +33% | +$2.3M |
|
|
6
Oracle
ORCL
$455B
| $9.12M | 9.06% |
160,000
+120,000
| +300% | +$6.49M |
|
|
7
Bristol-Myers Squibb
BMY
$128B
| $9.07M | 9.02% |
+200,000
| New | +$9.32M |
|
|
8
Walt Disney
DIS
$182B
| $6.98M | 6.94% |
50,000
-60,000
| -55% | -$7.96M |
|
9
AB InBev
BUD
$155B
| $4.63M | 4.6% |
52,300
-36,500
| -41% | -$3.13M |
|
|
K
10
DELISTED
Kellanova
K
| $3.21M | 3.2% |
63,900
-42,600
| -40% | -$2.26M |
|
11
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.2M | 3.18% |
15,000
+10,800
| +257% | +$2.23M |
|
|
12
Berkshire Hathaway Class A
BRK.A
$1.09T
| $3.18M | 3.17% |
10
+3
| +43% | +$933K |
|
|
13
The Kraft Heinz Company
KHC
$29.3B
| $3.1M | 3.09% |
100,000
-1,100,000
| -92% | -$34.7M |
|
|
14
PepsiCo
PEP
$182B
| $2.05M | 2.03% |
15,600
-65,900
| -81% | -$8.45M |
|
15
Capital One
COF
$124B
| – | – |
-45,012
| Closed | -$3.68M |
|
|
16
Qualcomm
QCOM
$202B
| – | – |
-82,755
| Closed | -$7.98M |
|
|
17
Restaurant Brands International
QSR
$25.6B
| – | – |
-70,139
| Closed | -$4.57M |
|
18
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.83B
| – | – |
-142,578
| Closed | -$3.24M |
|
Similar funds
ILI
WFS
GM
FWP
UCB
SG
RHP
NWMG
Naman Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Naman Capital held 18 positions worth $101M, up 27% from $79.4M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Naman Capital withdrew a net $39.2M in Q2 2019, closing 4 positions and reducing 6 holdings. Its most notable exit was Qualcomm, an estimated $7.98M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 14% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Naman Capital opened a new position in Bristol-Myers Squibb worth $9.07M.
- Naman Capital's largest Q2 2019 buy was Bristol-Myers Squibb: 200,000 shares worth $9.07M.
- Naman Capital added most to Merck in Q2 2019, an estimated $9.05M increase.
- Naman Capital's biggest Q2 2019 reduction was The Kraft Heinz Company, cutting an estimated $34.7M.
- Naman Capital fully exited Qualcomm in Q2 2019, selling an estimated $7.98M.
- Naman Capital's ten largest holdings make up 89% of its $101M portfolio in Q2 2019.
- Naman Capital opened 1 new position and closed 4 in Q2 2019.
- Naman Capital's portfolio value rose 27% quarter-over-quarter to $101M.
Based on Naman Capital's 13F filing for Q2 2019, filed 7 Oct 2022.